Dr. Masri and Dr. C. Michael Gibson discuss: Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis from ATTRibute-CM
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.